Electronic vs. Conventional Syringes: Impact on Pediatric Pain and Anxiety
Effectiveness of Electronic Anesthesia Delivery Syringe Versus Conventional Syringe on Pain and Anxiety Perception During Local Anesthetic Injection in Children Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Study Overview Purpose: To compare pain and anxiety levels in children aged 6-8 during local anesthesia administration using electronic vs. conventional syringes. Design: Split-mouth randomized controlled trial (RCT) involving 40 children receiving both types of anesthesia during pulp therapy of bilateral maxillary primary molars. Objectives Primary Outcome: Pain level measured via Visual Analogue Scale (VAS). Secondary Outcomes: Physiological markers: heart rate and oxygen saturation via pulse oximetry. Salivary amylase levels (anxiety biomarker) assessed using ELISA. Methodology Children are randomly assigned to receive electronic anesthesia on one side and conventional on the other in two separate visits. Saliva samples are collected before and after each injection. Double-blind setup: children blinded using sunglasses; statistician also blinded. Same operator administers all injections for consistency. Ethical Considerations Written informed consent and assent obtained. Risks (e.g., systemic toxicity, allergic reactions) minimized via dosage limits and patient monitoring. Privacy and data security measures in place. Statistical Analysis Data analyzed using SPSS; significance set at p ≤ 0.05. Sample size calculated for adequate power (n = 33 minimum; 40 enrolled). Funding Self-funded. Clinical Relevance Electronic anesthesia may offer a less painful and anxiety-inducing alternative for pediatric dental patients, potentially improving children's long-term attitude toward dental care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedJuly 31, 2025
December 1, 2024
8 months
May 28, 2025
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Perception
Tool: Visual Analogue Scale (VAS) Scale: 0 (no pain) to 10 (worst possible pain) Purpose: To quantitatively assess the child's subjective pain level post-injection.
Timing: Immediately after the administration of local anesthesia (both electronic and conventional)
Secondary Outcomes (3)
Heart Rate (HR)
Immediately before and after the administration of local anesthesia (both electronic and conventional)
Oxygen Saturation
Immediately before and after both the Electronic and Conventional anesthesia
Salivary amylase level
Before any injection (baseline) - After conventional anesthesia (The saliva samples must be collected up to 30 minutes after the injection) - After electronic anesthesia (The saliva samples must be collected up to 30 minutes after the injection)
Study Arms (2)
Maxillary right primary molar
ACTIVE COMPARATORMaxillary right primary molar will receive electronic anesthesia
Maxillary left primary molar
ACTIVE COMPARATORMaxillary left primary molar will receive conventional anesthesia
Interventions
The child will receive electronic anesthesia to the right side of the upper jaw; the pain and anxiety level will be assessed.
The child will receive conventional anesthesia to the maxillary left side
Eligibility Criteria
You may qualify if:
- year-old children.
- Medically free (ASA class I).
- Children attending their first dental visit.
- The patient should have at least one vital primary molar with deep carious lesion on each side.
You may not qualify if:
- Patient has any allergy to local anesthesia.
- Patients take any medications that affect the salivary flow.
- Patient taken corticosteroid.
- Children whose parents or legal guardians refuse to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Ain Shams university
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Reham Khaled Elghazawy, Associate professor
Faculty of Dentistry, Ain Shams university
- STUDY DIRECTOR
Nour Wahba, Lecturer/ Pedodontist
Faculty of Dentistry, Ain Shams university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Master's degree candidate at Pediatric department, Ain Shams University
Study Record Dates
First Submitted
May 28, 2025
First Posted
July 1, 2025
Study Start
December 1, 2024
Primary Completion
July 31, 2025
Study Completion
August 30, 2025
Last Updated
July 31, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
The Ethical committee refuse to share the patient information because of confidentiality